ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The purpose of the study is to assess the safety and tolerability of ALT-801 in diabetic and non-diabetic subjects with overweight and obese and non-alcoholic fatty liver disease (NAFLD).
Epistemonikos ID: 603762737a9eb7a25f4715a4f99fc8af5d9afe78
First added on: May 09, 2024